Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

57.47

+1.67 (2.99%)

At close: Mar 6, 2026, 4:00 PM EST

57.61

+0.14 (0.24%)

After-hours: Mar 6, 2026, 4:10 PM EST

Monopar Therapeutics Market Cap

Monopar Therapeutics has a market cap or net worth of $384.98 million as of March 6, 2026. Its market cap has increased by 54.08% in one year.

Market Cap

384.98M

Enterprise Value

241.41M

1-Year Change

54.08%

Ranking

#3237

Market Cap Chart

Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $384.98M, an increase of 39.41%. That is a compound annual growth rate of 5.49%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	384.98M	-11.78%
Dec 31, 2025	436.37M	225.25%
Dec 31, 2024	134.17M	2,552.79%
Dec 29, 2023	5.06M	-83.48%
Dec 30, 2022	30.62M	-24.23%
Dec 31, 2021	40.42M	-42.33%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NovaBridge Biosciences	403.52M
Autolus Therapeutics	401.88M
Crescent Biopharma	400.89M
PureTech Health	400.20M
Enanta Pharmaceuticals	392.92M
PepGen	390.83M
Benitec Biopharma	388.45M
Armata Pharmaceuticals	385.91M

Market Cap Rankings